# Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab

> **NCT01197144** · NA · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 70 (actual)

## Conditions studied

- Arthritis, Rheumatoid
- Pain
- Fatigue

## Interventions

- **DRUG:** adalimumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01197144
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2016-11-28
- **Final completion:** 2016-11-28
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01197144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01197144, "Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01197144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*